Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft vs. Host Disease (GvHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02806947
What this trial is testing

Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)

Who this might be right for
Acute GVHD
Medical College of Wisconsin 127
Testing effectiveness (Phase 2)Ended earlyNCT02619617
What this trial is testing

Safety and Efficacy Study of SOM230 s.c. in Cluster Headache

Who this might be right for
Cluster Headache - Episodic and Chronic
Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Looking for participantsNCT07340723
What this trial is testing

Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )

Who this might be right for
GVHD,AcuteStem Cell Transplant Complications
Daihong Liu 168
Not applicableLooking for participantsNCT06715046
What this trial is testing

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy 30
Testing effectiveness (Phase 2)Ended earlyNCT01226420
What this trial is testing

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Dana-Farber Cancer Institute 6
Testing effectiveness (Phase 2)Study completedNCT03846479
What this trial is testing

Itacitinib for Low Risk GVHD

Who this might be right for
Low Risk Acute Graft-versus-host DiseaseGraft-versus-host-diseaseGVHD
John Levine 70
Testing effectiveness (Phase 2)Study completedNCT00399308
What this trial is testing

Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers

Who this might be right for
Leg UlcerVaricose Ulcer
Shire 40
Early research (Phase 1)Study completedNCT01810718
What this trial is testing

Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft Versus Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 22
Not applicableActive Not RecruitingNCT04431479
What this trial is testing

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 211
Not applicableStudy completedNCT02991846
What this trial is testing

A Prospective Observational Study for Evaluating CGVHD

Who this might be right for
Chronic Graft-Versus-Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 248
Not applicableStudy completedNCT00579397
What this trial is testing

Markers of Inflammation in Hematopoietic Stem Cell Transplant

Who this might be right for
Acute Graft Versus Host Disease
Ann & Robert H Lurie Children's Hospital of Chicago 30
Post-approval studies (Phase 4)Study completedNCT00044720
What this trial is testing

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Who this might be right for
Chronic Kidney FailureGraft vs Host DiseaseKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 484
Testing effectiveness (Phase 2)Ended earlyNCT04111497
What this trial is testing

Glasdegib for Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host DiseaseFasciitis
Fred Hutchinson Cancer Center 15
Post-approval studies (Phase 4)Study completedNCT06751290
What this trial is testing

The Use of Cyproheptadine in Pediatric Feeding Disorders

Who this might be right for
Pediatric Feeding Disorder, ChronicAvoidant Restrictive Food Intake Disorder
University of Miami 18
Testing effectiveness (Phase 2)WithdrawnNCT00004878
What this trial is testing

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Not applicableNo Longer AvailableNCT01200017
What this trial is testing

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+9 more
Christopher Dvorak
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)WithdrawnNCT01616680
What this trial is testing

Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host Disease
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Early research (Phase 1)Ended earlyNCT04006652
What this trial is testing

ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients

Who this might be right for
Acute Graft Versus Host DiseaseHaploidentical Hematopoietic Stem Cell Transplant
Washington University School of Medicine 4
Testing effectiveness (Phase 2)Ended earlyNCT04941404
What this trial is testing

TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Glucocorticoid-Refractory aGVHD
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 13
Next Page